"Uncovering Long-COVID Signatures: Insights, Clues, and Treatment Advocacy"

Researchers have identified potential blood protein biomarkers for diagnosing and monitoring long COVID, a condition affecting an estimated 65 million people worldwide. A computational model based on the analysis of over 6,500 proteins in blood samples from COVID-19 patients suggests that immune response, blood clotting, and inflammation may play key roles in long COVID. The study's findings could pave the way for further research and potential therapies, although larger studies are needed to fully understand the underlying causes of the condition.